Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT06719167

A Pilot Research Project on Outcome of Trauma Informed Stabilization Treatment (TIST) for Adults with Complex Trauma Symptoms After Childhood Trauma, At the Department of Trauma Treatment, Modum Bad, Norway

Residential Group and Individual Trauma Informed Stabilization Therapy for Adult Survivors of Childhood Trauma

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
32 (estimated)
Sponsor
Modum Bad · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to examine the effects of residential group and individual Trauma Informed Stabilization Treatment (TIST) for complex symptoms in adult survivors of childhood trauma in a naturalistic observational study.

Detailed description

Adult survivors of childhood trauma have complex and diverse symptom profiles. The aim of the study is to examine the effects of theTrauma Informed Stabilization Treatment (TIST) model, developed by dr Janina Fisher, in adult survivors of childhood trauma. 32 patients will be recruited from referrals to an residential open door trauma clinic in Norway, Modum Bad. Patients will be admitted for in-patient pre-planned treatment over 11 weeks - consisting of individual therapy and group therapy using different modalities, all within the TIST approach and framework. Patients will be summoned for 6 day follow-up 8 months after treatment.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPsychoterapyDuring 11 weeks admission the programme will include group sessions using different modalities (psychoeducation videos, live psychoeducation groups, expressive arts therapy, equine facilitated therapy, mindfulness and discussion groups) all using TIST methodology. Parallell individual therapy with therapist (psychologist or psychiatrist) and milieu therapist. All therapists will be trained minimum in TIST level 1 and recieve supervision from an expert TIST therapist.

Timeline

Start date
2024-10-24
Primary completion
2026-07-01
Completion
2026-12-01
First posted
2024-12-05
Last updated
2024-12-05

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT06719167. Inclusion in this directory is not an endorsement.